Thursday, June 28, 2012
What's the best way to prevent asthma, and by extension, prevent deaths from asthma?
Posted by
Willow
at
2:01 pm
Labels: Acetaminophen, Asthma, asthma deaths, Calpol, childhood asthma, Dr Dinesh Saralaya, Dr Giuseppe Corbo, drug company profits, NHS, Novartis, paracetamol, Salt Intake, sodium intake, steroid inhalers, Tylenol
Friday, November 25, 2011
Novartis: Criminal Cover-Ups and Jawbone Damage from Zometa and Aredia
In a devastating blow to Novartis, a federal judge denied a bid to overturn a verdict in which a jury decided the drugmaker failed to adequately warn about the risks that its Zometa and Aredia bone-strengthening meds caused severe jaw bone damage. And in making his decision, he writes that the jury was shown sufficient evidence to conclude a cover-up was undertaken with “the knowledge and approval of high-ranking officials.”
Read article at pharmalot.com
Posted by
Willow
at
7:29 pm
Labels: Aredia, dangerous prescription drugs, jawbone damage, Novartis, Zometa
Friday, April 22, 2011
Conflicts of interest and the drug companies
Major philanthropic foundations, such as the Bill & Melinda Gates Foundation, regularly make the news with their donations and initiatives aimed at improving global health. But there is an aspect to their efforts that may be overlooked - such organizations can have links with drugmakers that could constitute a conflict of interest, according to an analysis published in PLoS Medicine.
Read article at pharmalot.com
The Dr Rath Health Foundation comments: The PLoS analysis adds significantly to the information about the Gates Foundation that was published by the Los Angeles Times in January 2007. In particular, the researchers found that several members of the Gates Foundation’s management committee, leadership teams, affiliates, and major funders are currently or were previously members of the boards or executive branches of major drugmakers, including Merck and Novartis. To examine the commercial network of the Bill & Melinda Gates Foundation, click here and here. For further information about Bill Gates, click here.
Posted by
Willow
at
8:26 pm
Labels: Bill and Melinda Gates Foundation, conflicts of interest, drug companies, Health, Merck, Novartis
Tuesday, November 09, 2010
Novartis Downplayed Bone Drugs' Risks, Lawyer Told Jurors
Novartis AG officials downplayed risks that the drugmaker’s bone-strengthening medicines Aredia and Zometa could destroy patients’ jaws, a lawyer for a woman suing the company told a North Carolina jury. Officials of the Basel, Switzerland-based drug company got reports from doctors as early as 2002 that Rita Fussman and other cancer patients taking Aredia and Zometa to prevent bone loss during treatment suffered irreplaceable jawbone damage, Bob Germany, a lawyer for Fussman’s family, said in opening statements in a trial over the medicines.
Read article at Bloomberg.com
Posted by
Willow
at
2:36 pm
Labels: adverse side-effects, Aredia, bone loss, jawbone damage, Novartis, Rita Fussman, Zometa
Friday, August 20, 2010
WHO reveals pandemic flu advisors with industry ties
Five of the 15 experts that advised the World Health Organisation about swine flu pandemic alerts had received support from the drugs industry, including for flu vaccine research, the WHO has revealed .
Read article at physorg.com
Comment by Dr Rath Foundation: The list of the WHO's influenza pandemic advisors with conflicts includes, amongst others, people with current and past grants and funding from GlaxoSmithKline, Novartis, Roche, Baxter, Sanofi Pasteur and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
Posted by
Willow
at
4:22 pm
Labels: Baxter, drug industry, Flu Pandemic, flu vaccine research, GlaxoSmithKline, IFPMA, Novartis, Roche, Sanofi Pasteur, WHO, World Health Organisation
Tuesday, May 04, 2010
Big Pharma to become Big Brother? Sinister move by Novartis.
Novartis has just purchased the technology to encapsulate a chip inside a pill that allows doctors—and government and Big Pharma and and the compliance police—to monitor how well you're following orders to take pills.
Read article at gaia-health.com
Posted by
Willow
at
9:23 am
Labels: Big Brother, Big Pharma, Novartis, prescribed drugs
Sunday, January 24, 2010
PACE to hold hearings on 'falsified' swine flu pandemic
PACE is to hold hearings on pharmaceutical companies' possible influence on the global swine flu campaign and on the World Health Organization, a Russian daily reported. "The 47-nation Parliamentary Assembly of the Council of Europe is conducting an inquiry into an alleged conspiracy between the WHO, the pharmaceutical industry and scientists which could "expose millions of healthy people to the risk of side-effects of insufficiently tested vaccines," caused damage to public budgets and to health agencies' credibility, according to a PACE resolution. The motion was introduced by Dr. Wolfgang Wodarg, head of the health committee, former German lawmaker and a specialist in lung disease, who called the current pandemic "one of the greatest medical scandals of the century." WHO declared the pandemic in June 2009 on the advice of a group of experts many of whom are believed to have financial ties with pharmaceutical giants like GlaxoSmithKline, Roche, Novartis, and benefited from the production of drugs and H1N1 vaccines."
Read article on the RIA Novosti website (Russia)
Comment: Russia's lower house of parliament, the State Duma, has apparently said that Russia should withdraw from the WHO if the corruption suspicions are proven.
Posted by
Willow
at
6:08 pm
Labels: corporate corruption of science, corruption, GlaxoSmithKline, Novartis, Pharmaceutical companies, Roche, Swine Flu vaccine, WHO, Wolfgang Wodarg
Monday, August 24, 2009
Might the swine flu vaccine increase the risk of cancer?
The swine flu vaccine has been hit by new cancer fears after a German health expert gave a shock warning about its safety. Lung specialist Wolfgang Wodarg has said that there are many risks associated with the vaccine for the H1N1 virus. He has grave reservations about the firm Novartis who are developing the vaccine and testing it in Germany. The vaccination is injected “with a very hot needle”, Wodarg said. The nutrient solution for the vaccine consists of cancerous cells from animals and "we do not know if there could be an allergic reaction". But more importantly, some people fear that the risk of cancer could be increased by injecting the cells.
Read article at bild.de (Germany)
Posted by
Willow
at
2:31 pm
Labels: cancer risk, Novartis, Swine Flu vaccine, Wolfgang Wodarg
Thursday, June 12, 2008
Novartis says experimental multiple sclerosis treatment FTY720 is linked to death and infection
Novartis SA, Switzerland's second- largest drugmaker, said a patient died and another developed a serious infection in tests of its experimental multiple sclerosis treatment FTY720.
Read article at bloomberg.com
Posted by
Willow
at
4:40 pm
Labels: adverse side-effects, MS, multiple sclerosis, Novartis, treatment FTY720
Thursday, August 16, 2007
Another arthritis painkiller - Prexige - made by Novartis - has caused fatalities
Doctors warned over arthritis drug after two die in Australia - Guardian
Extracts:
"Health campaigners last night urged doctors to be wary of prescribing an arthritis drug after concerns over its safety and an order to ban it in Australia following reports of liver damage. UK and European drug regulators are reviewing the safety data on the painkiller, Prexige, after eight cases of serious liver damage in Australia, including two fatalities.
There are concerns because Prexige is in the same class of drugs as Vioxx, the painkiller withdrawn worldwide in 2004 after being linked to heart attacks and strokes."
"In the UK approximately 5,400 patients have received one or more prescriptions for Prexige, made by the drugs company Novartis, in the last year.
Vioxx, which was manufactured by a separate drugs company, Merck, was used by 84 million patients worldwide, 400,000 of them in Britain. It was withdrawn after trials suggested it might nearly double the risk of heart attacks and strokes.
The class of drugs which includes Prexige and Vioxx is known as Cox-2 selective inhibitors. They are a relatively new type of anti-inflammatory medicine which is thought to produce fewer gastro-intestinal side effects than older non-steroidal anti-inflammatory drugs, which include ibuprofen. Since the Vioxx crisis they have been under surveillance by medicines watchdogs."
Cutting down on salt and salty food is helpful for reducing the pain of osteoarthritis and has many other health benefits too. - See conditions that can be helped by eating less salt
Lose weight by eating less salt! Go on! - Try it! - You will feel so much better!
How to Lose weight!
See my website http://www.wildeaboutsteroids.co.uk/.html
(The site does not sell anything and has no banners or sponsors or adverts - just helpful information.)
Read my Mensa article on Obesity and the Salt Connection
See Sodium in foods and
http://www.wildeaboutsteroids.co.uk/story.html - my 'political' page
http://www.wildeaboutsteroids.co.uk/socio.html - social and economic considerations
I can be contacted via my website if you need my further help. My help is free.
Posted by
Willow
at
3:21 pm
Labels: adverse side-effects, anti-inflammatory, arthritis, Cox-2 selective inhibitors, liver damage, Merck, Novartis, painkillers, prescribed drugs, Prexige, Vioxx
Monday, May 21, 2007
Coming soon: the shopping channel run by drug firms - Guardian
What a truly horrifying prospect! - Drug companies cannot be trusted to tell the truth...)o: And pharmaceutical drugs cause very great harm because of dangerous side-effects and because of reckless prescribing or wrong administration.
See http://aboutsalt.blogspot.com/search/label/Pharmaceutical%20industry and http://aboutsalt.blogspot.com/search/label/Pharmaceutical%20companies and http://aboutsalt.blogspot.com/2007/05/nhs-hospital-patients-dying-as-10000.html and http://aboutsalt.blogspot.com/search/label/Steroid%20Victims
Extract from the Guardian article:
"Four of the world's biggest pharmaceutical companies are proposing to launch a television station to tell the public about their drugs, amid strenuous lobbying across Europe by the industry for an end to restrictions aimed at protecting patients. Pharma TV would be a dedicated interactive digital channel funded by the industry with health news and features but, at its heart, would be detailed information from drug companies about their medicines.
A 10-minute pilot DVD, seen by the Guardian, featured a white-coated doctor discussing breast cancer and a woman patient who reassured viewers that "there are many new treatments available". Under the proposals, viewers could use their remote control to click on treatment options and read what manufacturers have to say about the latest branded breast cancer drugs.
Four companies, Johnson and Johnson, Pfizer, Novartis and Procter and Gamble, are behind the pilot, which they are offering to the European commission as a way to give patients more information. The commission is consulting on potential changes to the regulations that ban all direct-to-consumer advertising of medicinal drugs.
The industry has been lobbying in Europe to be allowed direct access to patients. It argues that lifting restrictions would help its competitiveness and has hinted that companies may relocate to the US, where they can advertise to patients who then demand drugs from their doctors. Profits have soared there as a result.
The proposed change in the rules is being led within the commission by its trade arm, DG Enterprise, and not health, DG Sanco. It is backed by a number of influential patient groups that are themselves heavily funded by drug companies. But consumer organisations are opposed, warning that the companies will play down risk, and that their real interest lies in boosting profits.
The International Society of Drug Bulletins (ISDB) - consumer publications which analyse the benefits of drugs and draw comparisons between them - warns that the industry is not a reliable source of trustworthy information.
The US and New Zealand allow drug companies to advertise to the public; the ISDB says in both these countries this has been shown to be detrimental to health.
"Pharmaceutical companies' messages are focused on relatively few top sellers, exaggerating effects and concealing risks, confusing patients and putting pressure on doctors to prescribe drugs they would not use otherwise," it says. "Lack of comparative information in advertising means people cannot choose among several options." Johnson & Johnson presented the companies' proposals to a meeting in Brussels of the Centre for Health, Ethics and Society, a thinktank which describes itself as "developed in partnership with Johnson & Johnson". The audience comprised members of the commission, patient groups and others."
Posted by
Willow
at
6:23 pm
Labels: DG Enterprise, European Commission, International Society of Drug Bulletins, ISDB, Johnson and Johnson, Novartis, Pfizer, Pharma TV, Pharmaceutical companies, Procter and Gamble, The Guardian
Thursday, May 03, 2007
A new osteoporosis drug
Osteoporosis drug offers women hope - Telegraph
Extracts:
"Women who are given an annual treatment for post-menopausal osteoporosis are less likely to suffer a broken hip or other fractures than those taking daily or weekly pills, according to a study to be published today.
Patients given a drip into the back of the hand of zoledronic acid, sold as Aclasta, cut the risk of hip breaks by 41 per cent and spinal breaks by 70 per cent compared to patients given a placebo.
Around half a million women in the UK take drugs such as alendronate and risedronate, known as bisphosphonates, in pill form daily or weekly to treat post-menopausal osteoporosis.
However, around half of patients stop taking the pills within a year.
The National Osteoporosis Society estimates that more than 60,000 hip and 120,000 spinal fractures take place each year in the UK.
Approximately one in five people die within three months of breaking their hip, which accounts for around 14,000 deaths annually.
Bone density is reduced in patients with osteoporosis, leading to greater risk of fractures.
Hormonal changes during the menopause put women at greater risk."
"Writing in The New England Journal of Medicine, lead researcher Prof Dennis Black, of the University of California, San Francisco, said: "During a three-year period, an annual infusion of zoledronic acid significantly reduced the risk of fracture at all key osteoporotic fracture sites including vertebral and hip fractures.
"A regimen of infusions once a year appears to ensure that patients will have a full treatment effect for at least 12 months.
"In contrast, many patients who receive prescriptions for oral bisphosphonates stop treatment, and most appear to be taking less than 80 per cent of their prescribed pills by 12 months."
The researchers said the infusion reduced the risk of spinal fractures by significantly more than the daily and weekly pills currently in use. Novartis, the company that manufactures the drug, hopes it will be available in the UK by the autumn."
"However, an abnormal heart rhythm, which can increase the risk of a stroke, was nearly three times more common among the 3,889 volunteers who took the Novartis drug.
The most common side effects with Aclasta were fever, muscle pain, flu-like symptoms, headache, and bone pain."
Osteoporosis can also be caused or exacerbated by 'slimming'/dieting. Give up dieting! - Safeguard your bone density by eating good, healthy meals and cutting down on salt and salty food.
Lose weight by eating less salt! Go on! - Try it! - You will feel so much better!
See my website www.wildeaboutsteroids.co.uk
(The site does not sell anything and has no banners or sponsors or adverts - just helpful information.)
Posted by
Willow
at
3:03 pm
Labels: Aclasta, alendronate, Bone density, eat less salt, Novartis, oral bisphosphonates, osteoporosis, Prof Dennis Black, risedronate, side-effects, spinal fractures, zoledronic acid

